However, expression for all 3 remaining genes – MN1, SPARC, and DHRS3 – was also upregulated in inv(16) AML (approximately 3-times higher than in CD34+ cells of healthy controls). The gene discussed is DHRS3; the disease is acute myeloid leukemia.